Quick Answer
CASI Pharmaceuticals, Inc. reported Gross Profit of $11.15 million for the year ending 2024.
- CASI Pharmaceuticals, Inc. showed a decrease of -44.4% in Gross Profit from 2023 to 2024.
- This data is from CASI Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2020 to 2024), CASI Pharmaceuticals, Inc.'s Gross Profit has grown by 97.9%.
- Historical annual values: Fiscal year 2024: $11.15 million | Fiscal year 2023: $20.05 million | Fiscal year 2022: $27.28 million | Fiscal year 2021: $17.61 million | Fiscal year 2020: $5.63 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: